» Articles » PMID: 1920626

Activity of CD4+ T-cell Clones of Type 1 and Type 2 in Generation of Influenza Virus-specific Cytotoxic Responses in Vitro

Overview
Journal J Virol
Date 1991 Nov 1
PMID 1920626
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of distinct CD4+ T-helper cell (Th) clones in promoting secondary A/PR/8/34/Mt.S.(H1N1) (A/PR8) influenza virus-specific, class I-restricted cytotoxic T-lymphocyte (CTL) responses in vitro was examined. CD8+ T cells which had been purified by fluorescence-activated cell sorter from spleen cells of A/PR8-primed mice were used as responders. On their own, purified CD8+ T cells were unable to generate cytotoxic activity upon in vitro culture with A/PR8-infected stimulator cells. Significant cytotoxic activity was generated in cultures that were additionally supplemented with A/PR8-specific Th clones or cell-free supernatant from these clones. Although there were large differences among individual Th clones in this function, Th clones of type 1 (Th1) promoted, on average, significantly stronger cytotoxic responses than Th clones of type 2 (Th2). The differences in promotion of a cytotoxic response correlated with the amount of interleukin-2 (IL-2) or IL-4 secreted by individual Th clones. These two lymphokines accounted for the CTL-promoting activity of the respective Th clones, since addition of recombinant IL-2 (IL-2) or rIL-4 to Th-free cultures substituted fully for the respective Th clones. As observed with Th clones, rIL-2 was significantly more effective than rIL-4 in promoting a cytotoxic response. When used in combination, Th2 clones had an antagonistic effect on the generation of a CTL response by Th1 clones. This effect could be partially transferred with cell-free supernatant from activated Th2 clones and could be reversed by addition of excess rIL-2. Both consumption of IL-2 by Th2 and secretion of an inhibitory factor(s) appear to be involved in this phenomenon.

Citing Articles

A computational approach to design a multiepitope vaccine against H5N1 virus.

Dashti F, Raisi A, Pourali G, Razavi Z, Ravaei F, Nahand J Virol J. 2024; 21(1):67.

PMID: 38509569 PMC: 10953225. DOI: 10.1186/s12985-024-02337-7.


Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9.

Tarrahimofrad H, Rahimnahal S, Zamani J, Jahangirian E, Aminzadeh S Sci Rep. 2021; 11(1):24485.

PMID: 34966175 PMC: 8716528. DOI: 10.1038/s41598-021-03932-2.


CD4 T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4 Cells.

Brenna E, Davydov A, Ladell K, McLaren J, Bonaiuti P, Metsger M Cell Rep. 2020; 30(1):137-152.e5.

PMID: 31914381 PMC: 7029615. DOI: 10.1016/j.celrep.2019.12.016.


Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.

Rumke H, Richardus J, Rombo L, Pauksens K, Plassmann G, Durand C BMC Infect Dis. 2013; 13:348.

PMID: 23890405 PMC: 3729430. DOI: 10.1186/1471-2334-13-348.


Hallmarks of CD4 T cell immunity against influenza.

McKinstry K, Strutt T, Swain S J Intern Med. 2011; 269(5):507-18.

PMID: 21362069 PMC: 3395075. DOI: 10.1111/j.1365-2796.2011.02367.x.


References
1.
Trenn G, Takayama H, Hu-Li J, Paul W, Sitkovsky M . B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes. J Immunol. 1988; 140(4):1101-6. View

2.
Takatsu K, Kikuchi Y, Takahashi T, Honjo T, Matsumoto M, Harada N . Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1987; 84(12):4234-8. PMC: 305059. DOI: 10.1073/pnas.84.12.4234. View

3.
Boog C, Boes J, Melief C . Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses. Eur J Immunol. 1988; 18(2):219-23. DOI: 10.1002/eji.1830180206. View

4.
Wysocka M, Bennink J . Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products. Cell Immunol. 1988; 112(2):425-9. DOI: 10.1016/0008-8749(88)90311-5. View

5.
Karasuyama H, Rolink A, Melchers F . Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts. J Exp Med. 1988; 167(4):1377-90. PMC: 2188910. DOI: 10.1084/jem.167.4.1377. View